Advertisement

Ads Placeholder
Loading...

Nephros, Inc.

NEPHNASDAQ
Healthcare
Medical - Instruments & Supplies
$2.87
$-0.06(-2.21%)
U.S. Market is Open • 10:31

Nephros, Inc. (NEPH) Stock Overview

Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap30.5M
P/E Ratio25.51
EPS (TTM)$0.11
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$1.97
3 Months$4.91
1 Year Target$6.57

NEPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nephros, Inc. (NEPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.51 and a market capitalization of 30.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.21%
5-Day Change
-1.37%
1-Month Change
-25.84%
3-Month Change
-39.58%
6-Month Change
-39.83%
Year-to-Date (YTD) Change
-39.58%
1-Year Change
34.74%
3-Year Change
151.75%
5-Year Change
-64.30%
All-Time (Max) Change
-99.73%

Contact Information

201 343 5202
380 Lackawanna Place, South Orange, NJ, 07079

Company Facts

310 Employees
IPO DateSep 21, 2004
CountryUS
Actively Trading

Frequently Asked Questions